Skip to Content
Skip to main content

The role of a novel MYB > (ATR-ATM-BUB1) axis in adenoid cystic carcinoma: therapeutic implications

Funder: Oracle Cancer Trust
Duration: September 2019 - August 2022


Name Telephone Email Office
Professor Arturo Sala Professor Arturo Sala
(Principal investigator)
T: +44 (0)1895 265547
+44 (0)1895 265547 Heinz Wolff 123A


CicirĂ², Y., Ragusa, D., Tejera Nevado, P., Lattanzio, R., Sala, G., DesRochers, T., et al. (2023) 'Identification of the mitotic checkpoint kinase BUB1 is a direct and actionable target of MYB in adenoid cystic carcinoma'. FEBS Letters, 0 (accepted, in press). ISSN: 0014-5793 Open Access Link

Journal article

CicirĂ², Y. and Sala, A. (2021) 'MYB oncoproteins: emerging players and potential therapeutic targets in human cancer'. Oncogenesis, 10 (2). pp. 1 - 15. ISSN: 2157-9024 Open Access Link

Journal article